Advertisement
Advertisement

QNTM

QNTM logo

Quantum BioPharma Ltd. - Class B (Sub Voting)

3.44
USD
-0.79
-18.68%
Dec 18, 15:59 UTC -5
Closed
...

Quantum BioPharma Ltd. - Class B (Sub Voting) Profile

About

Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Quantum BioPharma, formerly known as FSD Pharma Inc., is based in Toronto, Ontario.

Info & Links

CEO

Zeeshan Saeed

Headquarters

FIRST CANADIAN PLACE, 100 KING STREET WEST, SUITE 4000
TORONTO, A6 M5X 1A4, CANADA

Auditor

MNP LLP

Share holders

--

Employees

8

Quantum BioPharma Ltd. - Class B (Sub Voting) Statistics

Valuation Measures

Market Capitalization2

8.69M

Enterprise Value

5.87M

Enterprise Value/EBITDA(ttm)

-0.52

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.34

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-84.21%

Return on Invested Capital(ttm)

-89.98%

Return on Assets(ttm)

-62.63%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.20M

Net Income Available to Common(ttm)

-10.24M

Diluted EPS(ttm)

-15.41

Share Statistics

Beta (5Y Monthly)

0.59

52-Week Change

-94.91%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

1.75M

% Held by Insiders

8.53%

% Held by Institutions

1.24%

Balance Sheet

Total Cash(mrq)

6.61M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

300.50K

Total Debt/Equity(mrq)

1.96%

Current Ratio(mrq)

3.76%

Quick Ratio(mrq)

3.76%

Book Value Per Share(mrq)

8.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.58

Free Cash Flow(ytd)

-6.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement